[Treatments of benign prostatic hypertrophy and their cost-benefit relationship].
Rissanen
P
P
pekka.rissanen@stakes.fi
Salo
H
H
Helin-Salmivaara
A
A
Tammela
T
T
D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000191:economics* / Q000628:therapy*